Related Experiment Video
Updated: Dec 26, 2025

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Percutaneous Pulmonary Valve Implantation Based on Minimally Invasive Direct Coronary Bypass Surgery
Anoosh Esmaeili1, Stephan Fichtlscherer2, Tomas Holubec3
1Department of Children and Adolescent Medicine, Division of Pediatric Cardiology, Frankfurt University Hospital, Frankfurt am Main, Germany.
Abstract:
Approximately 5% of percutaneous pulmonary valve implantations (PPVIs) are at risk for coronary compression. Therefore, PPVI is contraindicated if coronary anomalies and tested coronary flow impairment are observed. Simultaneous right ventricular outflow tract ballooning and coronary angiography are mandatory elucidating contraindications for PPVI. We present the case of a 22-year-old woman who had Rastelli repair with chronic right heart failure. Weighing the risk of several offered surgical options, she underwent successful PPVI after minimally invasive direct coronary artery bypass procedure.

